familial Premature ovarian failure

Also Known As:

Premature ovarian failure, familial; Familial premature ovarian failure; Idiopathic familial premature ovarian failure

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	van Kasteren, Y M: 1 article (11/2000)

Drugs and Important Biological Agents (IBA) related to familial Premature ovarian failure:

1.	Estrogen ReceptorsIBA 05/28/1999 - "We studied five groups of women with ovarian dysfunction for the CGG expansion in FMR1 and a (TA)n polymorphism in the estrogen receptor gene: a) poor responders to ovarian stimulation as part of in vitro fertilization (n = 13); b) women with familial premature ovarian failure (POF) (n = 7); c) sporadic cases with POF (n = 16); d) FRAXA premutation carriers with POF (n = 7); and e) FRAXA premutation carriers without POF (n = 9). "
2.	Genetic Markers (Genetic Marker)IBA 11/01/1998 - "We therefore performed cytogenetic analyses on 79 women with primary or secondary amenorrhoea to assess the utility of screening for a genetic marker for familial premature ovarian failure. "

1.	Radiotherapy 11/04/2000 - "women from families with familial premature ovarian failure and women scheduled to undergo chemotherapy or radiotherapy at a young age."
2.	Drug Therapy (Chemotherapy) 11/04/2000 - "women from families with familial premature ovarian failure and women scheduled to undergo chemotherapy or radiotherapy at a young age."